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The functions of accessory cells in T-dependent responses to antigen appear to
be at least twofold. First, to present antigen in association with MHC molecules
for recognition by clonotypic antigen receptors on T cells; second, to promote acti-
vation and subsequent proliferation of antigen-specific T cells . Dendritic cells, in-
cluding mature Langerhans' cells, afferent lymph veiled cells, and lymph node in-
terdigitating cells appear to be unique accessory cells with respect toTcell activation
(1-4) . While a wide variety ofMHC class II-positive cells induce proliferation of
previously activatedT cells, only dendritic cells are capable of clustering with and
stimulating proliferation of normal resting T cells (5) .
It is suggested these dendritic cells represent different stages along a migratory
pathway that is related to their function . Langerhans' cells are believed to migrate
from the dermis through afferent lymphatic vessels in the form of veiled cells that
enterlymph nodes as interdigitating cells (6-8) . The functional significance of this
migration is the carriage ofantigen from the dermis to the paracortical areas of the
lymph node for presentation to T cells . Several observations support this scheme .
Langerhans' cells, veiled cells, and interdigitating cells in the mouse are recognized
by themAb NLDC-145, suggesting a common lineage for these cells (9) ; cells with
Birbeck granules, a marker of Langerhans' cells in some species, have been found
in afferent lymph and Tdependent areas oflymph nodes following skin sensitiza-
tion (6, 10); afferent lymph veiled cells and lymph node dendritic cells have been
isolated with antigen on their cell surface following skin painting with dinitrofluoro-
benzene (DNFB) t (11) and FITC (12), respectively .
The low number of dendritic cells in tissues and the lengthy fractionation proce-
dures required for their isolation have hampered studies on these cells . In the case
of afferent lymph dendritic cells, these problems may be overcome by the cannula-
tion of pseudo-afferent lymphatic vessels in relatively large experimental animals
(13, 14) . These lymphatics arise after lymphadenectomy when true afferent lym-
phatic vessels reanastomose with theformer efferent duct (15) . Lymph collected from
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these lymphatic vessels has a cellular composition similar to that of true afferent
lymph and includes 1-10% nonlymphoid MHC class II-positive dendritic cells (13,
16, 17). In this report, we describe the properties of dendritic cells collected from
sheep pseudo-afferent lymphatic vessels. In characterizing thesecells, we have devel-
oped a mAb that reacts with sheep CDl and identifies dendritic cells in afferent
lymph as well as skin and lymph node tissue. The expression of MHC class II and
CD1 by afferent dendritic cells suggests they are related to skin Langerhans' cells.
This is supported by our observation that afferent dendritic cells migrating from
a site of intradermal antigen challenge are able to present the injected antigen to
specific T cells in vitro. In an accompanying paper (18) we show the changes in MHC
Class II and CD1 expression by afferent dendritic cells as a consequence of in vivo
antigen challenge.
Materials and Methods
Antigens
Ovalbumin was obtained from Sigma Chemical Co. Ltd (cat. no. A5503, Grade V, Poole,
UK). Purified protein derivative of bovine tuberculin (PPD, batch 291) was kindly supplied
by the Central Veterinary Laboratory, Weybridge, UK.
Immunization and Secondary In Vioo Challenge of Animals
1-3-yr-old Finnish Landrace sheep of either sex were purchased from the Moredun Re-
search Institute, Edinburgh, Scotland. Sheep were immunized with 1 mg of ovalbumin in-
jected over two sites intramuscularly in a 1-ml mixture of PBS and CFA containing H37Ra
Mycobacterium tuberculosis. Sheep were also immunized with five human doses of Bacillus
Calmette-Guerin (BCG; Glaxo Laboratories Ltd., Greenford, UK). Secondary in vivo an-
tigen challenge of primed animals was by intradermal injection of 50 jig of antigen in 1 ml
of PBS into several sites around the drainage area of the cannulated pseudo-afferent lym-
phatic vessel.
Medium
RPMI 1640 (cat. no. 074-1800; Gibco Biocult, Uxbridge, UK) was supplemented with
2 MM L-glutamine, 100 U/ml benzyl penicillin and 100 U/ml streptomycin, 5 x 10-5 M
2-ME, and 2 g/liter sodium h
￿
rbonate. Culture medium consisted ofRPMI 1640 with sup
plements and 10% FCS (Flu
￿
-aboratories, Hertfordshire, UK). Wash medium consisted
of RPMI with supplements and 1% FCS.
Collection and Fractionation of Lymph Cells
Surgical techniques for the cannulation of the popliteal efferent lymphatic vessels were as
described by Hall et al. (19). Pseudo-afferent lymphatic cannulations were as those described
for the prefemoral lymphatic except that the node had been excised at least 6 wk previously
(13). Cannulations were allowed at least 3 d to stabilize after operative procedures. Lymph
was collected from fully conscious animals into sterile siliconized bottles containing 200 U
heparin and was centrifuged at 800g for 10 min to separate cells from lymph fluid. Mononuclear
lymph cells were harvested by centrifugation over Lymphoprep (Nyegaard, Oslo, Denmark).
Afferent Dendritic Cells.
￿
Afferent mononuclear cells were fractionated by centrifugation over
a discontinuous gradient of 14.5% (wt/vol) Metrizamide (Nyegaard) in RPMI 1640 plus 10%
FCS (20). Cells and density medium were cooled on ice then centrifuged for 30 min at 4'C
with 800 g applied to the interface ofcells and metrizamide. Purified afferent lymph dendritic
cells were collected from the top ofthe metrizamide gradient aftercentrifugation and washed
twice.
Efferent T Cells.
￿
Resting T cells were prepared from efferent lymphocytes after removal
of plastic adherent cells by incubation at 37°C for 1 h. Cells were then frationated by nylonBUJDOSO ET AL.
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fibercolumn according tojulius et al. (21). The nylonfiber nonadherent cells were routinely
>95% CD5' cells.
PeripheralBloodMonongclear Cells.
￿
PBMC were prepared by defibrination ofvenous blood
followed by centrifugation over Lymphoprep (22).
Generation ofAntigen-specific Cell Lines
Antigen-specific cell lineswere generated and recovered as described previously (23). Briefly,
PBMC, prepared from antigen-primed sheep, were cultured with antigen for 5 d. Viable
blast cells were expanded by culture for 14 d with fresh additions of 120 pM human rIL-2
(Biogen SA, Geneva, Switzerland) every 3-4 d. Viable cellswere harvested over Lymphoprep
and restimulated with antigen in the presence ofX-ray irradiated autologus PBMC and the
resultant blast cells were again expanded with rIL-2. Viable resting cells collected after this
second cycle of antigen stimulation and IL-2 expansion were stored under liquid nitrogen.
T Cell Proliferation
Resting T Cells.
￿
T cells were cultured in 96-well round-bottomed microculture plates in
a final volume of 200 pl. Triplicate cultures were stimulated with various numbers of X-ray
irradiated afferent or efferent mononuclear cells or fractionated dendritic cells.
Antigen-specific T Cell Lines.
￿
Antigen-specific T cells were recovered from storage under
liquid nitrogen as described elsewhere (23). Cells were cultured in 96-well flat-bottomed
microculture plates in a final volume of 200 pl. Triplicate cultures were stimulated with the
indicated number of X-ray irradiated autologous afferent dendritic cells that were collected
either before or at different times afterin vivo antigen pulsing. Appropriate exogenous soluble
protein was added to the cultures ofT cells and dendritic cells at the indicated concentrations.
Culture plates were incubated at 37°C for 5 d in a humidified atmosphere of 5olo
C02/95% air. Cells were pulsed with 1 pCi [3H]thymidine (specific activity, 2Ci/mmol;
Amersham Corp., UK) over the last 5 h ofculture then collected onto glass filter paper using
a semiautomated harvester. [3H]Thymidine incorporation was assessed by liquid scintilla-
tion counting. The data are expressed as the geometric mean for the triplicate cultures.
Dendritic-T Cell Clustering
A feature ofcocultures between T cells and dendritic cells is the formation ofdiscrete clusters
involving both cell types. To demonstrate these clusters resting T cells were cultured at 2
x 106/ml with irradiated unfractionated lymph cells or purified dendritic cells in 1 ml of
culture medium in 24-well plates. Cultures were incubated for 3 d at 370 C in a humidified
atmosphere of 5% C02/95% air. Clusters were photographed within the wells using an in-
verted Diavert microscope at x40 magnification.
X-Ray Irradiation
Cells were resuspended in culture medium to a concentration of 2 x 106/ml and irradi-
ated with 2,500 rad using a cobalt-cesium source.
Production of VPM5
BALB/c mice were immunized by intramuscular injection with 106 afferent lymph den-
dritic cells emulsified in 250 pl CFA, followed 3 wk later by the same inoculation given in-
traperitoneally, then intravenously with cells in PBS 4 d before fusion. Spleen cells from im-
munized micewere fused with the NSO cell line at a ratioof 1 :5, respectively (24). The products
of these fusions were seeded at 5 x 104 NSO cells/well in 96-well flat-bottomed plates. After
HAT selection, supernatants were screened on ELISAplates coated with I% paraformaldehyde-
fixed afferent lymph cells and hybrids from positive wells were cloned in soft agar. VPM5
was picked for further study.
Immunoprecipitation of VPM5 Antigen
Sheep thymocytes were treated with methyl-p-hydroxylbenzimidate HCl as described by
Wall and Fitch (25) then iodinated with 1251 catalyzed by lactoperoxidase and glucose oxi-1288
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dase. Cells were washed three times with PBS plus 0.1% sodium azide, resuspended at 5 x
107/ml, and aliquots of-2.5 x 107 cpm were mixed with 10 pl of VPM5 ascites fluid at 37°C
for 60 min. Cells were then lysed in 0.5 ml of 0.5% (vol/vol) Triton X-100 in 150 mM NaCl,
20 mM Tris-HCI, pH 8, and 0.2 mM PMSF at room temperature for 10 min. Cell debris
was removed by microfuging for 5 min at 16,000 g and the supernatant was incubated for
16 h at 4°C. Immune complexes were isolated by incubation for 1 h at 4°C with 50 JAI sheep
anti-mouse Ig Affigel 10 (10 mg affinity-purified antibody per milliliter affigel), (Bio-Rad
Laboratories, Watford, UK) . The beads were washed four times in lysis buffer and the com-
plexes were eluted by boiling in 50,ul SDS-elution buffer containing 5 % 2-ME. Eluted mate-
rial was separated by 5-20% linear gradient SDS-PAGE (26) followed by autoradiography
using Kodak XS-1 film.
Monoclonal Antibodies
SBU-1, SBUT4, SBUT6, and SBUT8 are mouse mAbs that recognize the sheep cell sur-
face glycoproteins MHC class I, CD4, CD1, and CD8, respectively (27-29). These were a
generous gift from Dr. M. Brandon (Melbourne, Australia). L/180/1 and 135-A are mouse
mAbs that recognize sheep LFA-3 (30) and CD2 (31), respectively, and were a generous gift
from Dr. T. Hunig, Max-Plank Institute, Munich, FRG. VPM8 is amouse monoclonal anti-
body generated in our laboratory that has specificity for sheep Ig light chain (Jones, P, and
I. McConnell, unpublished observation). SW73 .2 and VPM16 are rat mAbs and mouse mAbs,
respectively, that react with sheep MHC classII (Dutia, B., et al., manuscript in preparation).
Immunofluorescence and Immunohistology
Cells were washed twice with ice-cold PBS containing 1% BSA and 0.1% sodium azide
(PBS-BA). 1-2 x 106 cells/tube were treated with the appropriate dilution of mAb for 30
min on ice, washed twice with PBS-BA, and reacted with sheep anti-mouse Ig-FITC for
30 min on ice. Cells were washed three times with PBS-BA and fixed with 1% paraformalde-
hyde in PBS then stored at 4°C. Cells were analyzed by FACS using either a Becton Dick-
inson & Co. (Mountain View, CA) FACS IV or a FACScan system. 104 cells were analyzed
per sample with dead cells excluded on the basis offorward light scatter. The tissue distribu-
tion ofthe VPM5 antigen was by standard immunoperoxidase methods (32) using peroxidase-
labeled antiglobulin for tissue sections and gold-labeled antiglobulin (Jannsen Biochemica,
Beerse, Belgium) for smears.
Histochemical Staining
Staining for alkaline phosphatase, membrane ATPase, nonspecific esterase, and Sudan Black
was carried out by routine histochemical techniques (32).
Results
We have collected afferent lymph dendritic cells in order to study their role in
antigen carriage and presentation. A major problem associated with functional studies
on afferent lymph cells is that single afferent lymphatics are small and are difficult
to cannulate. These lymphatics have a low output of cells and lymph fluid. To over-
come this problem we have ablated peripherallymph nodes in sheep and subsequently
cannulated the pseudo-afferent lymphatic vessel that arises as a consequence ofafferent
lymphatic vessels reanastomosing with the former efferent duct. The pseudo-afferent
lymphatic vessel is easier to cannulate and routinely provides a greater output of
cells than does the cannulation of true afferent lymphatic vessels. In our character-
ization of afferent dendritic cells we have isolated a mAb that reacts not only with
these cells in afferent lymph but also dendritic cells in sheep peripheral lymphoid
organs. Functionl studies show that afferent dendritic cells are capable of stimulating
primary resting T cells and are involved in antigen carriage from the skin to draining
lymph nodes.Characterization and Distribution of VPM5Antigen.
￿
VPM5 (formerly AM) is amAb
isolated from mice immunizedwith purifiedafferent lymph dendritic cells. Themono-
clonal reacts in tissue sections with large nonlymphoid dendritic cells as described
in Table I. In lymph node tissue, positive cells are localized to the paracortical T
cell areas. The monoclonal does not stain all ofthe dendritic cells as VPM5- MHC
class II-positive dendritic cells can be identified in this area. VPM5+ cells within
this site might represent recently arrived migrants that subsequently lose VPM5
staining. Cells staining with VPM5 in the spleen are found predominately in the
inner periarteriolar lymphocyte sheath (PALS) around the central arteriole In the
thymus, nonlymphoiddendriticcells ofthe medullaand thecorticomedullar regions
stained with VPM5 asdid thymic cortical lymphocytes. Cells in theskinthat stained
with VPM5 were found within the dermis and at thejunction of the dermis and
epidermis. Cells were isolated from afferent and efferentlymphaswell as peripheral
blood. Positive cells were found only in afferent lymph and these were typical den-
dritic or veiled cells as described in afferent lymph of other species (33-35).
VPM5 staining is similar to that described for SBUT6, a mAb that recognizes
sheep CD1 (27) except that, unlike SBUT6, VPM5 doesnot stain peripheral blood
B cells or B cell follicles. SBUT6, however, reacts strongly in an ELISA with im-
munopurified VPM5 antigen (data not shown). The staining pattern ofVPM5 is
alsosimilarto that described fortwoanti-bovine CD1 mAbs, CC13 andCC14,which
crossreact with sheep tissue (36).
Immunoprecipitation of radiolabeled sheep thymocytes with VPM5 followed by
SDS-PAGE and autoradiography shows that VPM5 specifically precipitates poly-
peptides of48 and 12 kD (Fig. 1). The tissue distribution together with the molec-
ular mass of the antigen suggest that it recognizes sheep CD1. Furthermore, our
data suggest that it recognizes a subgroup of the antigen recognized by SBUT6.
Staining Pattern of VPM5 on Sections of Various Organs and on
Cytospin Preparations of In Vitro Isolated Cells
BUJDOSO ET AL.
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TABLE I
Staining oftissue sectionsand cytocentrifuge smears was carried out as described
in Materials and Methods.
Organ
VPM5
staining Cell type and localization
Spleen + Dendritic cells in PALS
Lymph node + Dendritic cells in paracortex
Thymus + Cortical thymocytes
Medullary dendritic cells
Skin + Dendritic cells within the dermis and at the
junction of the dermis and epidermis
Peyer's patch
Brain
Heart
Kidney
Liver
In vitro isolated cells
PBMC -
Afferent lymph + Dendritic cells
Efferent lymph -1290
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FIGURE 1 .
￿
Autoradiograph ofthe material immunoprecipitated from
1251-labeled sheep thymocytes using control (lane 1) and VPM5 (lane
2) ascites.
Isolation and Characterization ofAfferent Dendiitic Cells.
￿
Lymphcollected from apseudo-
afferent cannulation contains cells at aconcentration of 1-5 x 106/ml . The cellular
composition of afferent lymph cells (Table II) contains 1-10% VPM5` cells that are
largenonlymphoid dendritic cells . Enriched populations of dendritic cellswere pre-
pared by centrifugation of afferent mononuclear cells on a single density band of
14.5% metrizamide, accordingto the method of Knight et al . (20). After this, apopu-
lation of cells that are routinely >75% dendritic cells, as seen by light microscopy,
may be recovered from the top of the density gradient . Approximately 106-107 den-
dritic cells could be harvested by this technique after fractionating a 16-h collection
of afferent cells . Afferent lymphocytes and some of the dendritic cells pass through
this concentration ofmetrizamide . Purified dendritic cells were stained with a panel
ofmouse anti-sheep leukocyte mAbs and analyzed by flow cytometry (Table III) .
Contaminatinglymphocytes that were mainlyT cells and <5% B cells were excluded
from the analysis on the basis oftheirlowerforward and side scatter compared with
dendritic cells . All of the dendritic cells expressed high levels ofMHC class I and
class II molecules . The majority of dendritic cells reacted withVPM5 mAb, confirming
the expression ofCDl by these cells (27) . Afferent dendritic cells were stained by
themAb 135/A, which identifies sheepCD2, aligand ofLFA-3 (30) . VPM8, a mono-
clonal that reacts with sheep Ig light chain, stainedthe majority ofafferent dendritic
TAELE II
Staining of VPM5 in Lymph Compartments of the Sheep
Percentage positive cells
Source of cells
￿
CD5
￿
slg
￿
VPM5
￿
Class II
Efferent
￿
67.2 (7.0)
￿
22 .8 (7 .0)
￿
<0 .5 (0.06)
￿
29.4 (7 .1)
Afferent
￿
83.4 (2 .2)
￿
11 .0 (8.1)
￿
8.2 (10.8)
￿
57 .0 (5 .3)
Afferent and efferent lymph mononuclear cells were stained with mouse mAbs
followed by rabbit anti-mouse Ig-FITC . Cells were fixed with 1% paraformalde-
hyde and analyzed by flow cytometry . The data shown are the mean of four
experiments with the standard deviation in parentheses .Afferent lymph dendritic cells were isolated as described in Materials and Methods
then stained with mouse mAbs followed by (Fab)2 rabbit anti-mouse Ig-FITC.
Cells were fixed with 1 % paraformaldehyde and analyzed by flow cytometry.
These results were seen in three of three experiments.
cells. The sIg+ cells in afferent lymph, therefore, include some of the dendritic cells,
in contrast to efferent lymph where the sIg+ cells are all small lymphocytes (Table
II). A representative sample of fluorescence staining of the dendritic cells analyzed
by a Becton Dickinson & Co. . FACScan is shown in Fig. 2. The results show afferent
dendritic cells displaying unimodal marginal positivity for CD4 expression. When
analyzed by a Becton Dickinson & Co. FAGS IV (Table III), these cells show no
reactivity with anti-CD4 mAbs. The data also show afferent dendritic cells have a
uniform expression of LFA-3and MHC class II. Theexpression of LFA-3is ofequiva-
lent intensity as shown by afferent lymphocytes while the level of MHC class II ex-
pression by afferent dendritic cells is 3-10 greater than resting B cells.
Although we cannot exclude the possibility that the purified population of den-
dritic cells includes macrophage cells, histochemical staining of fractionated den-
dritic cells showed no staining for the macrophage markers nonspecific esterase or
Sudan Black. Positive staining was seen for membrane ATPase and alkaline phos-
phatase. We have also found that sheep macrophages collected by bronchiolar la-
vage do not express VPM5 or CD2.
Log fluorescence intensity
TABLE III
Phenotype of Afferent Lymph Dendritic Cells
BUJDOSO ET AL.
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FIGURE 2.
￿
Immunofluorescence profile ofaffer-
ent dendritic cells stained with various mAbs.
Afferent lymph dendritic cells were isolated as de-
scribed in Materials and Methods then stained
with anti-CD4, anti-LFA-3, or anti-MHC class
II mAbs followed by (Fab)2 rabbit anti-mouse
Ig-FITC. Cells were fixed with 1% paraformalde-
hyde and analyzed by FACScan flow cytometry.
These results were seen in three ofthree experi
ments. (. . . .) Control, (-) CD4, (
￿
) LFA-3,
(---) MHC class II.
Name Antigen
Reactivity with
dendritic cells
SBU-T4 CD4 -
SBU-T6 CD1 +
SBU-T8 CD8 -
VPM5 CD1 + +
L/180/1 LFA-3 + + +
I35/A CD2 +
VPM8 sIg +
SBU-1 Class I + + +
SW73.2 Class II + + +1292
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The results shown here, in particular the expression ofCDl and MHC class II
by afferent dendritic cells, together with the results of Hein et al . (17) and Mackay
et al . (28), suggest that afferent dendritic cells are lymph-borne Langerhans' cells
or amigratory intermediatory between Langerhans' cellsand interdigitating cells (9).
Accessory Functions ofAfferent LymphDendritic Cells.
￿
Both afferent and efferent lymph
compartments contain MHC class II-positive cells and therefore the potential to
act as accessory cells forT lymphocyte responses to antigen. This potential hasbeen
analyzed in this studyby measuring the primaryT cell response to alloantigen . Fig.
3 shows cocultures of allogeneic afferent or efferent lymph cells with restingT cells .
Clustering does not occurwhen autologous (Fig . 3 A) or allogeneic (Fig . 3B) efferent
lymph cells are mixedwith restingT cells . In contrast, when unfractionated allogeneic
afferent mononuclear cells are cultured with restingT cells, small and infrequent
clusters develop (Fig . 3 C) . With purified allogeneic afferent dendritic cells as stimu-
lators, larger and more frequent clusters are seen compared with cultures with un-
fractionated afferent cells (Fig . 3 D) . Within these clusters one or more dendritic
cells could be seen surrounded by numerous lymphocytes .
Afferent and efferent lymph cells differ in their ability to stimulate the prolifera-
tion ofrestingT cells . Fig . 4A shows that unfractionated allogeneic afferent lymph
cells stimulate proliferation of resting T cells but allogeneic efferent cells do not .
This proliferative response can be stimulated by purified afferent dendritic cells, as
shown in Fig . 4B . At high numbers of stimulator cells/well, autologous dendritic
cells stimulate a response ofsimilar magnitude to that stimulated by allogeneic den-
FIGURE 3 .
￿
10'/well nylon fiber nonadherent resting efferent lymph T cells were cultured with
irradiated lymph cells . (A) 105/well autologous efferent T cells . (B) 10'/well allogeneic efferent
cells . (C) 10'/well allogeneic afferent cells . (D)5 x 10'/well allogeneic fractionated afferent den-
dritic cells . Cultures were incubated for 3 d in 24-well plates. Cells were photographed at x40
magnification .BUJDOSO ET AL.
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Stimulate cells/well x I(T3
FIGURE 4.
￿
Tcell proliferation stimulated by afferent dendritic cells. 105/Well nylon fiber nonad-
herent resting efferent lymph Tcells were cultured with irradiated lymphcells in round-bottomed
microculture plates with either (A) irradiated unfractionated afferent or efferent lymph cells or
(B) irradiated fractionated autologous or allogeneic dendritic cells. Cultures were incubated for
3 d and proliferation was measured by the uptake of [3Hlthymidine over the last 5 h of culture.
The data is expressed as the geometric mean of counts per minute from triplicate cultures.
dritic cells. As the number of stimulator cells/well is reduced then only allogeneic
dendritic cells stimulate a significant response by the T cells. Although we have not
demonstrated that proliferating cells arise from within these clusters, significant
[3Hlthymidine uptake did not occur in the absence of cluster formation.
Both afferent and efferent lymph contains MHC class II-positive cells, yet only
afferent lymph cells are capable of clustering and activating resting T cells. These
functions can be carried out by enriched populationsofafferent dendritic cells showing
the similarity between these and other isolated dendritic cells in stimulating pri-
mary responses by T cells to antigen (5).
Afferent Dendritic Cells AreInvolved in Antigen Carriage.
￿
We have investigated the hy-
pothesis that dendriticcells are involved in antigencarriage from the skin to draining
lymph nodes. Dendritic cells were collected 24 h after an intradermal injection of
soluble protein antigen into the drainage area of apseudo-afferent cannulation then
cultured in the absence of exogenous antigen with antigen-specific cells prepared
from the same animal.
Table IV shows theproliferative response ofPBMC, from primed animals, stimu-
TABLE IV
The Response of PBMC to Autologous In Vivo Pulsed Dendritic Cells
105 PBMC/well were cultured with 5 x 104/well irradiated fractionated affer-
ent dendritic cells collected either before or at 24 h after an intradermal injec-
tion of antigen into the drainage area of the pseudo-afferent cannulation area.
Cultures were incubated for 3 d and proliferation measured by the uptake of
[3Hlthymidine over the last 5 h of culture. The data are expressed as the geo-
metric mean of counts per minute from triplicated cultures.
Antigen pulse
Dendritic
cells
Collection
Pre-pulse
of dendritic cells (h)
24 h after
antigen challenge
Ovalbumin (50 hg) - 6,330 4,443
+ 5,078 10,777
PPD (20 lAg) - 2,143 2,132
+ 3,189 8,7341294
￿
SHEEP AFFERENT LYMPH DENDRITIC CELLS
lated by autologous in vivo antigen-pulsed dendritic cells. Dendritic cells collected
after in vivo antigen challenge stimulate a significant response above that seen with
pre-challenge dendritic cells. This response is seen when either ovalbumin or PPD
is used to antigen pulse dendritic cells in vivo. These data show that dendritic cells
may at least pick up antigen in vivo and either present antigen directly to T cells
or pass the material to other accessory cells within the PBM population. To distin-
guish between these, the experiment was repeated using antigen-specific T cell lines
that do not respond to antigen in the absence of added accessory cells (23). Table
V shows dendritic cells, collected after in vivo antigen challenge with ovalbumin,
stimulate asignificant proliferativeresponse by ovalbumin-specific T cells compared
with that induced by pre-challenge dendritic cells. This effect is antigen specific as
no response is seen by PPD-specific T cells. In Exp. 2, dendritic cells collected after
in vivo antigen challengewith PPD stimulate a significant proliferative response by
the PPD-specific cell line. No response is seen by the ovalbumin-specific T cells to
the PPD-pulsed dendritic cells. The proliferation of antigen-specific T cells is de-
pendent upon the number of in vivo pulsed dendritic cells added to the cultures.
Fig. 5 shows the response stimulated by antigen-specific Tcells to various numbers
of ovalbumin-pulsed dendritic cells collected after in vivo antigen challenge. A
significant response is seen by the ovalbumin-specific cell line down to 1.9 x 103
dendritic cells/well. In contrast, the PPD-specific cell line shows a background level
ofproliferation to all concentrations of added dendritic cells. The experiments de-
scribedinTableVand Fig. 5 were set up at the same time. Asin vivoantigen pulsed
afferent dendritic cells were the only accessory cells added to these cultures these
data show that these cells can directly stimulate T cells in an antigen-specific manner
and do so with antigen acquired in vivo.
It may be argued that the failure to see proliferation by the PPD-specific cell line
with ovalbumin-pulsed dendritic cells, or the ovalumin-specific cell line with PPD-
pulsed dendritic cells, isdueto the cell lines failingto surviveliquid nitrogen storage.
To showthiswas not the case, antigen-specific T cells were cultured with exogenous
specific antigen in the presence ofdendritic cells pulsed with nonspecific antigen.
The results are shown in Table VI. On each day ofrecovery from liquid nitrogen
TABLE V
The Response of Cell Lines to Autologous In Vioo Pulsed Dendritic Cells
5 x 104 ovalbumin-specific or PPD-specific T cells/well were cultured with 5 x
104/well irradiated fractionated afferent dendritic cells collected either before or
at 24 h after an intradermal injection of antigen into the drainage area of the
pseudo-afferent cannulation drainage area. Cultures were incubated for 3 d and
proliferation measured by the uptake of [3H]thymidine over the last 5 h of cul-
ture. The data areexpressed as the geometric mean counts per minute from tripli-
cate cultures.
Antigen pulse Cell line
Collection
Pre-pulse
of dendritic cells
24 h after
antigen challenge
Ovalbumin (50 ug) Ovalbumin 5,704 169,588
PPD 2,709 3,978
PPD (20 /+g) Ovalbumin 1,032 3,654
PPD 1,212 20,0400
x
E a
V
V c
E
x
200
BUJDOSO ET AL.
Number of dendritic cells/well x 10-2
TABLE VI
The Response of Cell Lines to Specific Antigen with
In Vioo Pulsed Dendritic Cells
FIGURE 5.
￿
Response ofcell lines to var-
ious numbers of dendritic cells pulsed in
vivo with ovalbumin. 5 x 104 ovalbumin-
specific or PPD-specific T cells/well were
cultured with various numbers of irradi-
ated fractionated afferent dendritic cells
collected 24 hafter in vivo antigen pulsing
with 50 hg ovalbumin. Cultures were in-
cubated for3d andproliferation measured
by the uptake of [3H]thymidine over the
last 5 hofculture. Thedataare expressed
as the geometric mean ofcounts per min-
ute from triplicate cultures.
Collection of dendritic cells
5 x 104 ovalbumin-specific or PPD-specific Tcells/well were cultured with 5 x
104/well irradiated fractionated afferent dendritic cells collected either before or
at 24 hafter an intradermalinjection of antigen into the drainage area of the
pseudo-afferent cannulation area. T cells were cultured with dendritic cells in
the absence or presence of 27 jug/ml soluble protein antigen. Cultures were in-
cubated for 3 dandproliferation measured by the uptake of [3H]thymidine over
the last 5 h ofculture. Thedata are expressed as the geometric mean of counts
per minute from triplicate cultures.
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the PPD-specific cell line, while showingno response to ovalbumin-pulsed dendritic
cells alone, clearlyresponded to PPD antigen presented by the same dendritic cells.
Similarly, the ovalbumin cell line responded to ovalbumin in the presence ofPPD-
pulsed dendritic cells. These data confirm theviability ofcells recovered from liquid
nitrogen.
Collectively, the data described in Tables V and VI show the ability of afferent
dendriticcells to acquiresoluble protein antigeneither in vivo or in vitro for presen-
tation to autologous Tcells. As these experiments were set up at the same time they
also show that as a population, the dendritic cells are able to present more than
one antigen at a time.
Discussion
Dendritic cells first isolated from tissue sites by Steinman have been shown to be
potent accessory cells for T cell responses to antigen (reviewed in 37). The in vivo
Antigen Antigen
pulse Cell line (27 1&g/ml)
Ovalbumin PPD -
PPD Ovalbumin -
Pre-pulse
24 h after
antigen challenge
5,704 3,282
136,593 122,980
1,325 4,822
110,584 150,7061296
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correlates of isolated dendritic cells include epidermal Langerhans' cells, afferent
lymph veiled cells, and lymph node interdigitating cells. Furthermore, it is postu-
latedthat these dendritic cells represent intermediates alongapathway of migration
involved in the carriage of antigen to lymph nodes (8). While information has been
described for Langerhans' cells and lymph node interdigitating cells in this scheme,
little data are available concerning the role of afferent lymph dendritic cells. Here
we report on the isolation and characterization ofdendritic cells from sheep afferent
lymph. These cells are obtained by the cannulation of pseudo-afferent lymphatic
vessels that arise after lymphadenectomy of peripheral nodes. A 16-h collection of
lymph from these cannulations may contain between 106 and 10' dendritic cells. The
bulk of these may be harvested at a purity of >75o7o following asingle density-gradient
centrifugation step. The ability to collect afferent dendritic cells in large numbers,
and in high purity, provides an opportunity to characterize and investigate the role
ofthese cellsin antigen carriage and presentation ofsoluble proteinantigento Tcells.
We have found that sheep afferent dendritic cells, like human and mouseLanger-
hans' cells, express CDl. This family of molecules is best described in the human
system where three subgroups are defined, CDla, CDlb, and CDlc, that have gly-
cosylated heavy chains of 49, 45, and 43 kD, respectively, and that can be differen-
tiated on the basis of their tissue distribution (38). All the anti-human CDl mAbs
stain cortical thymocytes, but while anti-CDla monoclonals stain both dermal and
epidermaldendritic cells, CDlb monoclonals stainonly dermal dendriticcells. Anti-
CD1c mAbs can be differentiated by their ability to stain B cells (39). The tissue
distribution of VPM5 antigen is similarto that ofthe human CDlb antigen. VPM5
tissue staining resembles that of the anti-bovine CDl monoclonals CC13 and CC14
(36), but differs from that of the sheep anti-CDI marker SBUT6 in that VPM5
does not stain B cells (27). SBUT6, however, reacts strongly with VPM5 antigen.
These data show that in the sheep the CDl antigen consists ofmore than oneproduct
anddemonstrate that there are reagents that can differentiate theseproducts. Sheep
afferent dendritic cells express high levels of surface molecules involved in antigen
recognition by T cells. The expression of MHC class I and class 11 molecules allows
afferent dendritic cells the potential to present antigen to CD8+ and CD4+ T cells
(40). The level of MHC class II expression by afferent dendritic cells is approxi-
mately three times that seen on resting B cells (41). A feature of some dendritic cells
is the ability to form clusters with resting T cells and is likely to involve an interac-
tion between cellular adhesion molecules (42). LFA-3 was found on afferent den-
dritic cells at levels approximately equalto those on afferent lymphocytes. A human
lymphoblastoid cell line has been described with two forms of cell surface LFA-3
(43). One of these is linked to the membrane by a hydrophobic transmembrane re-
gion followed by an intracytoplasmic tail. The other lacks the intracytoplasmic tail
and is linked to the membrane by a phosphatidylinositol glycan moiety attached
to the COOH terminus of the LFA-3 molecule. This second type oflinkage hasbeen
identified on membrane proteins involved in transmembrane signaling, interleukin
release, and intercellular adhesion (44). Ifboth forms of LFA-3 arepresent on afferent
dendritic cells then adichotomy of function might exist for this molecule. One form
may act as an anchor for clustering with T cells while the other may be involved
in signal transduction andcytokine release. It is reported that perturbation ofLFA-3
on human macrophages by anti-LFA-3 induces IL-1 release (45). We are currentlyBUJDOSO ET AL.
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investigating thelinkage and function of LFA-3 on afferent dendritic cells. Afferent
dendritic cells were found to express CD2, a ligand for LFA-3 (46), on their cell
surface. We do not know at the present whether this is due to expression of a CD2
gene or adsorption of the molecule (47) as a consequence of the high level of LFA-3
shown by dendritic cells.
Dendritic cellsare potent accessorycells forT cell responses but significant differ-
ences exist in the accessory potential displayed by different dendritic cells. In vitro
cultured mouseepidermal Langerhans'cells, like spleen dendritic cells, form clusters
with restingT cells, whereas fresh Langerhans' cells do not (48). Fresh Langerhans'
cells have similar amounts of MHC class II molecules to splenic dendritic cells and
although levels increase during in vitro culture, it does not appear to be the sole
determinant of this increasedaccessorypotential. Amaturation step formouseLanger-
hans' cells has been demonstrated in vitro that can be mediated by recombinant
granulocyte/macrophage colony-stimulating factor (GM-CSF) (49). As suggested
by others (49), Langerhans'cells may differentiate in theepidermisundertheinfluence
of cytokines from keratinocytes and macrophages that produce GM-CSF and IL-1.
Both of these cytokines increase the accessory function of dendritic cells and may
allow Langerhans' cells to mature into competent accessory cells as they pass into
afferent lymph.
A prediction of the hypothesis that afferent dendritic cells are involved in antigen
carriage from the dermis to lymph nodes is that antigen deposited in the dermis
should, at some stage, be associated with these cells. We have demonstrated that
this is the case by a functional assay. Afferent dendritic cells collected from the site
ofan intradermal challenge with solubleprotein antigen were able to induce prolifer-
ation ofautologous antigen-specific Tcell lines, in the absence of exogenousantigen
or other accessory cells. Previous studiesthat have investigated this have shown that
in vivo antigen-pulsed dendritic cells stimulate T cell proliferation but fail to distin-
guish between an antigen-specific response and that which occurs as a result of in-
creased nonspecific accessory function (12, 50). The data presented here, together
with the studies showing the localization of antigen on afferent veiled cells or lymph
node dendritic cells after antigen challenge at the skin (11, 12), provide strong evi-
dence for a direct role by dendritic cells in the carriage of antigen to lymph nodes.
It is not clear how dendritic cells acquire and transport soluble protein antigen in
vivo. It has been customary to assume that antigen becomes cell associated as a re-
sult of nonspecific pinocytosis and/or phagocytosis. However, Langerhans' cells and
lymphoid dendriticcells fail to accumulate thepinocytotic tracer horseradish perox-
idase and are regarded as poorly phagocytic (48). Recent studies by Lanzavecchia
have shown that efficient uptake and presentation of antigen occurs only when an-
tigen interacts in a specific manner with the presenting cell. This is demonstrated
by antigen-specific EBVtransformed B cells that can present specific antigenat much
lower concentrations than do nonspecific cells (51). Second, MHC class II-positive
T cell clones only present antigen that binds with high affinity to their cell mem-
brane such as recombinant HIV gp120 protein interacting with CD4 (52). Ourob-
servation that afferent dendriticcells have Ig on theircell surface reinforces thefindings
by Miller and Adams (53) that dendritic cells display membrane-associated IgM.
This may reflect naturalantibody passively acquired by the dendriticcells that func-
tions as a receptor for antigen. The subsequent interaction of antigen with this anti-1298
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body would allowforeign material to enter an antigen processing pathway that would
exclude self material. A separation of foreign and self material is unlikely to occur
if the process of uptake occurs by a nonspecific mechanism. By using antigen-anti-
body complexes, dendritic cells in vivo may efficiently concentrate and process small
amounts ofantigen. This may be particularly important during a primary response
to soluble antigen for which dendritic cells appear to be the principal antigen-presenting
cell .
It has become clear that dendritic cells play a major role in the pathogenesis of
persistent viral infections by members of the lentivirus family. HIV infects CD4+
cells(54) and part ofthe immunosuppression caused by this virus is due to an altera-
tion of CD4+ accessory cell function. Visna virus, the sheep lentivirus, also infects
accessory cells including macrophages (55). The data reported here and in the ac-
companying paper (18), which describes the alterations ofafferent dendritic cell MHC
class II and CDl expression as a consequence of in vivo antigen challenge, provide
parameters with which to assess the role of infected dendritic cells in lentivirus infection.
Summary
We have ablated peripheral lymph nodes in sheep and subsequently cannulated
the pseudo-afferent lymphatic vessel that arises as a consequence of afferent lym-
phatic vessels reanastomosing with the former efferent duct. This technique allows
the collection oflymph with a cellular composition that resembles true afferent fluid,
and in particular, containing 1-10% dendritic cells. A 16-h collection of this lymph
may contain between 106 and 107 dendritic cells. This dendritic cell population may
be enriched to >75To by a single-density gradient centrifugation step. We have gener-
ated a mAb that recognizes sheep CDl. This monoclonal not only reacts with afferent
dendritic cells, but with dendritic cells in the skin and paracortical T cell areas of
lymph nodes. The expression of CD1 suggests afferent dendritic cells are related
to skin Langerhans' cells and other dendritic cells that act as accessory cells for T
cell responses. Consistent with this is the high level of expression by dendritic cells
of molecules involved in antigen recognition by T cells, including MHC class I and
class II. Afferent dendritic cells express high levels of the cellular adhesion molecule
LFA-3, and at the same time express a ligand for this molecule, namely CD2 . The
accessory functions of afferent dendritic cells resemble those displayed by mature
Langerhans' cells and by lymph node interdigitating cells. These include clustering
with resting T cells and stimulating their proliferation in a primary response to an-
tigen. Afferent dendritic cells are capable of acquiring soluble protein antigen in
vivo or in vitro and presentingthe material directly to autologous T cellsin an antigen-
specific manner. We conclude that afferent dendritic cells represent a lymph-borne
Langerhans' cell involved in antigen carriage to the lymph node.
We thank Dr. Alan Munro for his valuable and stimulating discussions in the preparation
of these experiments.
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